193 related articles for article (PubMed ID: 19010144)
1. Treatment of renal transplant failure.
Morales A; Gavela E; Kanter J; Beltrán S; Sancho A; Escudero V; Crespo J; Pallardó LM
Transplant Proc; 2008 Nov; 40(9):2909-11. PubMed ID: 19010144
[TBL] [Abstract][Full Text] [Related]
2. Intolerance syndrome in failed renal allografts: incidence and efficacy of percutaneous embolization.
Delgado P; Diaz F; Gonzalez A; Sanchez E; Gutierrez P; Hernandez D; Torres A; Lorenzo V
Am J Kidney Dis; 2005 Aug; 46(2):339-44. PubMed ID: 16112054
[TBL] [Abstract][Full Text] [Related]
3. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
[TBL] [Abstract][Full Text] [Related]
4. Nonfunctioning renal allograft embolization as an alternative to graft nephrectomy: report on seven years' experience.
Atar E; Belenky A; Neuman-Levin M; Yussim A; Bar-Nathan N; Bachar GN
Cardiovasc Intervent Radiol; 2003; 26(1):37-9. PubMed ID: 12491018
[TBL] [Abstract][Full Text] [Related]
5. Fever, infection, and rejection after kidney transplant failure.
Woodside KJ; Schirm ZW; Noon KA; Huml AM; Padiyar A; Sanchez EQ; Sarabu N; Hricik DE; Schulak JA; Augustine JJ
Transplantation; 2014 Mar; 97(6):648-53. PubMed ID: 24637864
[TBL] [Abstract][Full Text] [Related]
6. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
7. Successful steroid withdrawal after long-term administration in renal transplant patients.
Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
[TBL] [Abstract][Full Text] [Related]
8. Late steroid withdrawal after heart transplantation and incidence of acute rejection.
Crespo-Leiro MG; Paniagua MJ; Franco R; Marzoa R; Grille Z; Naya C; Barge E; Rios R; Rodríguez JA; Calviño R; Cuenca JJ; Castro-Beiras A
Transplant Proc; 2007 Sep; 39(7):2372-4. PubMed ID: 17889193
[TBL] [Abstract][Full Text] [Related]
9. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
[TBL] [Abstract][Full Text] [Related]
10. [Embolization of non-functioning renal allograft: efficacy and control of systemic inflammation].
Pérez Martínez J; Gallego E; Juliá E; Llamas F; López A; Palao F; Lorenzo I; López E; Illescas ML; Gómez Roldán C
Nefrologia; 2005; 25(4):422-7. PubMed ID: 16231510
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients without any immunosuppressive therapy after renal allograft failure.
Naini AE; Harandi AA; Daemi P; Kosari R; Gharavi M
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):59-61. PubMed ID: 18087124
[TBL] [Abstract][Full Text] [Related]
12. Graft intolerance syndrome in children with failed kidney allografts--clinical presentation, treatment options and outcome.
Krause I; Cleper R; Belenky A; Atar E; Bar-Nathan N; Davidovits M
Nephrol Dial Transplant; 2008 Dec; 23(12):4036-40. PubMed ID: 18586765
[TBL] [Abstract][Full Text] [Related]
13. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
14. Benefits derivated from late steroid withdrawal in renal transplant recipients.
Gavela E; Avila A; Sancho A; Kanter J; Beltrán S; Crespo JF; Pallardó LM
Transplant Proc; 2007 Sep; 39(7):2173-5. PubMed ID: 17889128
[TBL] [Abstract][Full Text] [Related]
15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
16. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
17. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
18. Sudden late onset of gross hematuria in a previous renal transplant recipient 3 months after transplant nephrectomy.
Nanovic L; Becker YT; Hedican S; Hofmann RM
Am J Kidney Dis; 2005 Nov; 46(5):e91-4. PubMed ID: 16253716
[TBL] [Abstract][Full Text] [Related]
19. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Lee PC; Zhu L; Terasaki PI; Everly MJ
Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
